Complexation of the anti-Trypanosoma cruzi Drug Benznidazole Improves Solubility and Efficacy

Journal of Medicinal Chemistry
2008.0

Abstract

The ruthenium complex, trans-[Ru(Bz)(NH 3) 4SO 2](CF 3SO 3) 2 1, Bz = benznidazole ( N-benzyl-2-(2-nitro-1 H-imidazol-1-yl)acetamide), is more hydrosoluble and more active (IC 50try/1 h = 79 +/- 3 microM) than free benznidazole 2 (IC 50try/1 h > 1 mM). 1 also exhibits low acute toxicity in vitro (IC 50macrophages > 1 mM) and in vivo (400 micromol/kg < LD 50 < 600 micromol/kg) and the formation of hydroxylamine is more favorable in 1 than in 2 by 9.6 kcal/mol. In murine acute models of Chagas' disease, 1 was more active than 2 even when only one dose was administrated. Moreover, 1 at a thousand-fold smaller concentration than the considered optimal dose for 2 (385 micromol/kg/day = 100 mg/kg/day), proved to be sufficient to protect all infected mice, eliminating the amastigotes in their hearts and skeletal muscles as observed in H&E micrographics.

Knowledge Graph

Similar Paper

Complexation of the anti-Trypanosoma cruzi Drug Benznidazole Improves Solubility and Efficacy
Journal of Medicinal Chemistry 2008.0
1,2,3-Triazole-based analogue of benznidazole displays remarkable activity against Trypanosoma cruzi
Bioorganic &amp; Medicinal Chemistry 2015.0
Ruthenium complexes endowed with potent anti-Trypanosoma cruzi activity: Synthesis, biological characterization and structure–activity relationships
Bioorganic &amp; Medicinal Chemistry 2009.0
In Vitro and in Vivo Trypanosomicidal Activity of Pyrazole-Containing Macrocyclic and Macrobicyclic Polyamines: Their Action on Acute and Chronic Phases of Chagas Disease
Journal of Medicinal Chemistry 2012.0
New Promising Compounds with in Vitro Nanomolar Activity againstTrypanosoma cruzi
ACS Medicinal Chemistry Letters 2013.0
On the search for potential anti-Trypanosoma cruzi drugs: Synthesis and biological evaluation of 2-hydroxy-3-methylamino and 1,2,3-triazolic naphthoquinoidal compounds obtained by click chemistry reactions
European Journal of Medicinal Chemistry 2012.0
In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives
Journal of Medicinal Chemistry 2016.0
Novel nitroimidazole derivatives evaluated for their trypanocidal, cytotoxic, and genotoxic activities
European Journal of Medicinal Chemistry 2020.0
In Vivo Trypanosomicidal Activity of Imidazole- or Pyrazole-Based Benzo[g]phthalazine Derivatives against Acute and Chronic Phases of Chagas Disease
Journal of Medicinal Chemistry 2011.0
Second Generation of Mannich Base-Type Derivatives with in Vivo Activity against Trypanosoma cruzi
Journal of Medicinal Chemistry 2018.0